Arca Biopharma reported $3.5M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 15.69B 1.36B
Biogen BIIB:US USD 3.27B 653.6M
Brainstorm Cell Therapeutics BCLI:US USD 8.95M 1.1M
Cytokinetics CYTK:US USD 84.62M 8.12M
Cytrx CYTR:US USD 3.1M 633.56K
Daiichi Sankyo 4568:JP JPY 457.07B 28.97B
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Laboratory Of America LH:US USD 3.08B 556.2M
Myriad Genetics MYGN:US USD 137.2M 8.1M
Otsuka Holdings 4578:JP JPY 539.19B 4.81B
United Therapeutics UTHR:US USD 343.2M 27.3M